Skip to main content
OpenTrials
Completed

NCT Number: NCT04036318

Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs)

Sexually transmitted infections (STI) are important causes of reproductive health morbidity and mortality, and have long been implicated as major co-factors in the sexual transmission of HIV. Both ulcerative and non-ulcerative STI have been found to be strongly associated with HIV in cross-sectional and prospective studies and hence STI prevention and care are important aspects of HIV prevention.

Periodic Presumptive Treatment of STIS (PPT) where risk populations are presumptively treated with a single dose of Azithromycin+Cefixime in regular intervals of 3 months has been shown to be effective in reducing STI prevalence at population level and has recently been integrated into the National STI guidelines of Tanzania. The USAID funded Sauti program will be one of the first to implement these new guidelines and roll out PPT in high risk populations in selected regions in Tanzania. This study will evaluate the impact of PPT as delivered by the Sauti program on prevalence of STIs in men who have sex with men and female sex workers in Dar es Salaam and Shinyanga respectively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sexually Transmitted Diseases, Bacterial Bacterial Infections Bacterial Infections and Mycoses Blood-Borne Infections Communicable Diseases Disease Attributes Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Pathologic Processes Pathological Conditions, Signs and Symptoms RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Shinyanga Region, Shinyanga, Kahama, Tanzania

Loading trial locations.

About this study

This intervention linked study evaluates the impact of PPT on population level in FSW and MSM in Tanzania (Shinyanga and Dar es Salaam respectively). It is expected that PPT will reduce laboratory diagnosed STIs by 50% in the population after a roll out of 6 months.

This evaluation uses a cross-sectional venue-based sampling design. Three rounds of cross sectional data collection will be undertaken for MSM in Dar es Salaam and FSW in Shinyanga at three months intervals (baseline, 3 months and 6 months). The change in prevalence will be measured between baseline and 6 months assessments. The interim assessment will be used to refine the sample size. Study participants will be recruited in venues frequented by FSW (Shinyanga) and MSM (Dar es Salaam) in wards where Sauti operates. Respondents will be continuously sampled from all venues until sample size is reached. In each round of data collection, study participants will undergo physical examination, biological specimen collection, laboratory and HIV tests and a questionnaire.

STI prevalence in MSM and FSWs will be measured during each survey and laboratory-confirmed STI prevalence (gonorrhoea, chlamydia, syphilis) will be assessed.

Additionally, effect on STI prevalence in the bridge population will be measured by retrospective analysis of routine data for the prevalence of syndromic STIs among the mining population in Shinyanga, as collected in the context of the Sauti program mobile biomedical services (CBHTC+), which will visit the major mines in Shinyanga prior PPT implementation and after each survey. By the term major mines, we mean mines with large population of male mine workers (between 1000-2000 male mine workers) at higher risk of HIV rather than mines with modern mining infrastructure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Willing to give oral informed consent
  • 18 years of age or older
  • Is referred from the pre-selected recruitment venues and present and recruitment card.
  • Sexually active in the last 6 months
  • At least half of self-reported monthly income is generated through sex work (FSWs only)
  • Men who engage in sexual relations with other men regardless of the motivation (MSMs only)

Exclusion criteria

  • Not willing to give informed consent
  • Not sexually active in the last 6 months
  • State of intoxication from recreational drugs or alcohol use or other reasons which would prevent voluntary and informed consent to the study as judged by investigator
  • Pregnant women - (determined through pregnancy screening questions used by Sauti)
  • Does not have a study referral card

Treatment and study plan

Primary outcomes

  1. Reduction of prevalence of laboratory confirmed bacterial STIs

    Time frame: After six months of periodic presumptive treatment of STIs

    Reduction in prevalence of laboratory confirmed STIs (a combined measure of gonorrhea, chlamydia and Treponema pallidum) in men who have sex with men (MSMs) in Dar es Salaam and female sex workers (FSWs) in Shinyanga after six months of presumptive treatment of STIs (PPT).

  2. Reduction of prevalence of syndromic STIs

    Time frame: After six months of periodic presumptive treatment of STIs among FSW in Shinyanga

    Syndromic STI prevalence (Genital ulcers disease (GUD), Anorectal Syndrome (ARS), Urethral Discharge Syndrome (UDS), Painful scrotal swelling (PSS)) among male clients of FSW in Shinyanga mines (bridge population) after six months of availability of PPT to FSWs. initiation.

Secondary outcomes

  1. Associations between demographic, socio-economic, behavioral and biological risk factors, STI prevalence and PPT impact.

    Time frame: After six months of periodic presumptive treatment of STIs among FSW in Shinyanga

    The association will determined by using the logistic regression

  2. Changes in sexual risk taking behaviors while receiving PPT

    Time frame: Six months

    Changes in sexual risk behaviors will be determined by comparing the baseline prevalence and prevalence after six months of PPT

  3. Prevalence of cervical cancer lesions

    Time frame: Six months

    The prevalence of cervical cancer lesions, will be assessed through Visual Inspection with Acetic Acid (VIA), among the FSW in the study.

  4. Prevalence of Human Papilloma Virus (HPV), HIV, Hepatitis B and C

    Time frame: Six months

    The prevalence of Human Papilloma Virus (HPV), HIV, Hepatitis B and C will be assessed from the bio-specimens of serum and genital swabs collected during the surveys

Sponsors and collaborators

Lead sponsor

National Institute for Medical Research, Tanzania

Other Gov

Registry information

Official study title

Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs) Among High-risk Populations Including Men Who Have Sex With Men, Female Sex Workers (FSW) and Mining Populations in Tanzania.

Acronym: PPT

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jul 29, 2019
Registry last updated
Sep 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.